A detailed history of Simplex Trading, LLC transactions in Morpho Sys Ag stock. As of the latest transaction made, Simplex Trading, LLC holds 4,464 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,464
Holding current value
$0
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$0.0 - $18.96 $0 - $84,637
4,464 New
4,464 $0
Q1 2024

Apr 25, 2024

SELL
$8.6 - $18.18 $1.01 Million - $2.14 Million
-117,755 Reduced 96.04%
4,859 $88,000
Q4 2023

Feb 02, 2024

BUY
$4.55 - $9.9 $543,429 - $1.18 Million
119,435 Added 3757.0%
122,614 $1.21 Million
Q3 2023

Nov 01, 2023

BUY
$6.72 - $8.6 $20,556 - $26,307
3,059 Added 2549.17%
3,179 $21,000
Q2 2023

Aug 04, 2023

BUY
$3.95 - $7.74 $474 - $928
120 New
120 $0

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.